- Bottomline (EPAY:$16.39,00$-0.12,00-0.73%) has seen steady sell pressure move into the shares late tonight since the company announced plans to sell stock in an offering.
- EPAY, -3.5%, 16.51 to 14.50 , stock offering.
- Short, but look for some bargain hunters if it drops too low.
- Martek Biosciences (MATK:$19.25,00$0.99,005.42%) firmed in evening trade after beating Q2 estimates.
- MATK, +6.9%, 18.26 to 21.48, beats with Q2 results.
- Long, but I'd wait a few hours to see what happens.
- Quiksilver (ZQK:$4.63,00$-0.02,00-0.43%) advanced in after-hours trade after topping Q2 expectations.
- ZQK, +11.5%, 4.63 to 5.40, beats Street expectations.
- Long, but its inflated, look for profit takers early on and a cheap buy before run up, then possible short.
- Navarre (NAVR) reports Q4 sales of $138.3 mln, better than the analyst mean of $121 mln on Thomson Reuters. Earnings were $0.09 per share, vs. expectations of $0.04 per share.
- NAVR: +25%, 2.10 to 2.29, beats with Q4 results.
- Short, only short this after it runs, if not, Long, it after it dips.
- Dyncorp International (DCP:$17.03,00$0.08,000.47%) reports Q4 EPS of $0.43 vs $0.34 a year earlier and topping the Thomson Reuters mean analyst estimate for $0.35.
- DCP, +0.8%, 17.03 to 17.20, topped Q4 estimates.
- Short, didn't really kill earnings, but could have small pop, but I expect it to come down.
- Ulta Salon, Cosmetics & Fragrance Inc (ULTA:$23.90,00$0.31,001.31%) posted a higher-than-expected quarterly profit, helped by improved merchandise margins, and the company forecast strong second-quarter results
- ULTA, +2.5%, 23.59 to 26, higher than expected quarterly profit.
Long, I like how it bounced high came down, think it will make a strong run and come down hard tomorrow just the same, good plays both long and short here. - Trubion Pharmaceuticals Inc.'s (TRBN:$3.68,00$-0.24,00-6.12%) shares jumped in after-hours trading, after the company disclosed an appeals board in Europe upheld a decision to revoke a patent held by Roche Holding AG's (RHHVF:$139.5000,$0.0000,0.00%) (RHHBY, ROG.VX) Genentech and Biogen Idec Inc. (BIIB:$49.25,00$0.90,001.86%) .
- TRBN, +7%, 3.72 to 4.75, revoked patent in favor.
- (RCMT:$3.50,00$0.0052,0.15%) today announced that its Board of Directors has met with respect to the proposal by CDI Corp (CDI:$16.32,00$0.69,004.41%) to acquire all of the outstanding shares of RCM common stock for $5.20 per share, and has determined that it would not be in the best interests of the Company to pursue the transaction as presently structured by CDI Corp.
- RCMT, +40%, 4.10 to 5.44, not going through with deal.
- Long on RCMT, Short, on CDI.
- ADRs of China Finance Online (JRJC:$7.08,00$0.39,005.83%) were up sharply after the company soundly beat first-quarter estimates.
- JRJC, +10.9%, 7.30 to 8.11, beat Q1 estimates.
- Long/Short, major break-out territory so I'd be careful either way you choose to play it.
- Krispy Kreme (KKD:$3.69, up to 4.1afterhours) Recording Upside Range of 3.75 to High of 4.03 in After-Hours.
- KKD, +4.6%, 3.69 to 4.03, first-quarter net earnings more than doubled.
- Short the early gain, chart shows its weak so people holding are going to want to take profit, although there is some strong upside on the positive earnings.
- Washington Mutual Inc's (WAMUQ:$0.1250,$0.0060,5.04%) effort to exit bankruptcy encountered a setback on Thursday when the judge in the case ordered the company to talk further with shareholders about their requests for documents
- Long Scalp, This could be good for the future of shareholders since they got fucked in the first deal, could be some movement on this stock tomorrow, I say yes.
- Hercules Offshore (HERO:$2.92,00$0.29,0011.03%) is up after theStreetInsider.com reports that the CEO bought 30,000 shares while a VP bought 25,000 shares.
- Price: 2.89, Change: +0.26 , Percent Change: +9.91
- Companies like this will thrive for 6 months along with the moratorium signed by Pres.
- Long, wait for a dip, or a big dump and bounce it back to profit land.
6.03.2010
Preview June 4
